DLG2 expression is negatively correlated with MYCN amplification and its location on chromosome 11q, a common chromosomal deletion in unfavourable neuroblastomas, further validates that it is a potential neuroblastoma prognostic biomarker [21]. The gene discussed is MYCN; the disease is neuroblastoma.